Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPL
801
CALL
PPL Corp
PPL
$26.4B
| $27.8M | 0.01% |
804,300
+302,500
| +60% | +$10.9M |
|
|
P
802
CALL
DELISTED
Pandora Media Inc
P
| $27.8M | 0.01% |
1,940,200
+1,068,500
| +123% | +$14.4M |
|
|
ANDV
803
CALL
DELISTED
Andeavor
ANDV
| $27.8M | 0.01% |
349,300
-199,300
| -36% | -$15.4M |
|
804
CALL
Waste Management
WM
$90.5B
| $27.7M | 0.01% |
433,900
+26,000
| +6% | +$1.7M |
|
805
PUT
Oceaneering
OII
$5.02B
| $27.6M | 0.01% |
1,004,200
+975,800
| +3,436% | +$27M |
|
806
PUT
Acadia Pharmaceuticals
ACAD
$5.11B
| $27.6M | 0.01% |
867,500
| – | – |
|
|
POT
807
CALL
DELISTED
Potash Corp Of Saskatchewan
POT
| $27.6M | 0.01% |
1,690,300
-377,400
| -18% | -$6.23M |
|
808
Freeport-McMoran
FCX
$112B
| $27.5M | 0.01% |
2,533,909
+2,431,609
| +2,377% | +$28M |
|
809
CALL
Melco Resorts & Entertainment
MLCO
$2.08B
| $27.5M | 0.01% |
1,705,400
+250,900
| +17% | +$3.53M |
|
|
XLNX
810
PUT
DELISTED
Xilinx Inc
XLNX
| $27.4M | 0.01% |
504,800
-132,000
| -21% | -$6.78M |
|
811
PUT
ProShares Ultra Bloomberg Crude Oil
UCO
$401M
| $27.4M | 0.01% |
211,376
+65,496
| +45% | +$8.05M |
|
812
Humana
HUM
$46.4B
| $27.4M | 0.01% |
154,676
+103,184
| +200% | +$17.9M |
|
813
PUT
3D Systems Corp
DDD
$518M
| $27.3M | 0.01% |
1,523,300
-489,200
| -24% | -$7.34M |
|
814
PUT
Edwards Lifesciences
EW
$52.2B
| $27.2M | 0.01% |
676,500
-327,900
| -33% | -$12.3M |
|
815
CALL
Gen Digital
GEN
$17.4B
| $27.2M | 0.01% |
1,082,700
+475,300
| +78% | +$10.8M |
|
816
PUT
Workday
WDAY
$49.2B
| $27.2M | 0.01% |
296,300
-110,200
| -27% | -$9.19M |
|
|
MDCO
817
CALL
DELISTED
Medicines Co
MDCO
| $27.1M | 0.01% |
717,400
+518,400
| +261% | +$19.5M |
|
|
RHT
818
DELISTED
Red Hat Inc
RHT
| $27M | 0.01% |
333,863
+327,667
| +5,288% | +$24.4M |
|
|
MRO
819
PUT
DELISTED
Marathon Oil Corporation
MRO
| $27M | 0.01% |
1,705,800
+388,500
| +29% | +$5.77M |
|
820
CALL
Stryker
SYK
$126B
| $26.9M | 0.01% |
231,500
-50,900
| -18% | -$5.93M |
|
821
CALL
Avis
CAR
$5.19B
| $26.9M | 0.01% |
787,500
-265,900
| -25% | -$9.63M |
|
822
PUT
Estee Lauder
EL
$37.7B
| $26.9M | 0.01% |
304,000
+229,400
| +308% | +$20.9M |
|
|
ENDP
823
CALL
DELISTED
Endo International plc
ENDP
| $26.9M | 0.01% |
1,335,600
+752,900
| +129% | +$15M |
|
824
PUT
Franco-Nevada
FNV
$52.1B
| $26.9M | 0.01% |
384,500
-233,900
| -38% | -$17.5M |
|
|
CELG
825
DELISTED
Celgene Corp
CELG
| $26.7M | 0.01% |
255,782
+252,344
| +7,340% | +$27.3M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.